NEUROPROTECTION FOR ISCHEMIC STROKE: PAST, PRESENT AND FUTURE

Por Ginsberg, Myron D.
Publicado em 2008

Current Status of Neuroprotection for Cerebral Ischemia Synoptic Overview

Por Ginsberg, Myron D.
Publicado em 2008

VISUALIZING THE CORTICAL MICROCIRCULATION IN STROKE PATIENTS

Por Ginsberg, Myron D.
Publicado em 2011

SYMPTOMATIC INTRACRANIAL HEMORRHAGE IN THE ALIAS MULTICENTER TRIAL: RELATIONSHIP TO ENDOVASCULAR THROMBOLYTIC THERAPY

Por Ginsberg, Myron D., Hill, Michael D.
Publicado no Int J Stroke (2015)

Albumin Therapy Improves Local Vascular Dynamics in a Rat Model of Primary Microvascular Thrombosis A Two-Photon Laser-Scanning Microscopy Study

Por Nimmagadda, Anitha, Park, Hee-Pyoung, Prado, Ricardo, Ginsberg, Myron D.
Publicado em 2007

Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window

Por Ley, James J., Belayev, Ludmila, Saul, Isabel, Becker, David A., Ginsberg., Myron D.
Publicado em 2007

Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study

Por DeFazio, Richard A, Zhao, Weizhao, Deng, Xiaolu, Obenaus, Andre, Ginsberg, Myron D
Publicado em 2012

Albumin Therapy Augments the Effect of Thrombolysis on Local Vascular Dynamics in a Rat Model of Arteriolar Thrombosis: A Two-Photon Laser-Scanning Microscopy Study

Por Park, Hee-Pyoung, Nimmagadda, Anitha, DeFazio, Richard A., Busto, Raul, Prado, Ricardo, Ginsberg, Myron D.
Publicado em 2008

Neuroprotective Antioxidant STAZN Protects Against Myocardial Ischemia/Reperfusion Injury

Por Ley, James J., Prado, Ricardo, Wei, Jian Qin, Bishopric, Nanette H., Becker, David A., Ginsberg, Myron D.
Publicado em 2007

Albumin in Acute Stroke (ALIAS) Trials: Analysis of the combined data from Parts 1 and 2

Por Martin, Renee’ H., Yeatts, Sharon D., Hill, Michael D., Moy, Claudia S., Ginsberg, Myron D., Palesch, Yuko Y.
Publicado no Stroke (2016)

The Albumin in Acute Stroke (ALIAS) Part 1 Trial: An exploratory efficacy analysis

Por Hill, Michael D., Martin, Renee, Palesch, Yuko, Tamariz, Diego, Ryckborst, Karla J., Moy, Claudia S., Barsan, William G., Ginsberg, Myron D.
Publicado em 2011

A web-based medical safety reporting system for a large multicenter clinical trial - The ALIAS experience

Por Zhao, Wenle, Waldman, Bonnie D., Dillon, Catherine, Pauls, Keith, Kim, Jaemyung, Patterson, Lynn, Ginsberg, Myron D., Hill, Michael D., Palesch, Yuko
Publicado em 2010

THE ALBUMIN IN ACUTE STROKE (ALIAS) MULTICENTER CLINICAL TRIAL: SAFETY ANALYSIS OF PART 1, AND RATIONALE AND DESIGN OF PART 2

Por Ginsberg, Myron D., Palesch, Yuko Y., Martin, Renee H., Hill, Michael D., Moy, Claudia S., Waldman, Bonnie D., Yeatts, Sharon D., Tamariz, Diego, Ryckborst, Karla
Publicado em 2010

High-dose albumin treatment for acute ischaemic stroke (ALIAS): a phase 3, randomised, double-blind, placebo-controlled trial

Por Ginsberg, Myron D., Palesch, Yuko Y., Hill, Michael D., Martin, Renee H., Moy, Claudia S., Barsan, William G., Waldman, Bonnie D., Tamariz, Diego, Ryckborst, Karla J.
Publicado em 2013

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial

Por Hill, Michael D., Martin, Renee H., Palesch, Yuko Y., Moy, Claudia S., Tamariz, Diego, Ryckborst, Karla J., Jones, Elizabeth B., Weisman, David, Pettigrew, Creed, Ginsberg, Myron D.
Publicado no PLoS One (2015)